Harvey Investment Co. LLC Purchases 190 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Harvey Investment Co. LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,841 shares of the healthcare conglomerate’s stock after acquiring an additional 190 shares during the period. Harvey Investment Co. LLC’s holdings in UnitedHealth Group were worth $2,449,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Lecap Asset Management Ltd. boosted its holdings in shares of UnitedHealth Group by 457.2% during the 4th quarter. Lecap Asset Management Ltd. now owns 5,633 shares of the healthcare conglomerate’s stock worth $2,850,000 after buying an additional 4,622 shares in the last quarter. Golden State Wealth Management LLC acquired a new stake in UnitedHealth Group in the fourth quarter worth $867,000. Archer Investment Corp raised its holdings in shares of UnitedHealth Group by 10.3% during the fourth quarter. Archer Investment Corp now owns 2,777 shares of the healthcare conglomerate’s stock valued at $1,405,000 after purchasing an additional 259 shares during the period. Beese Fulmer Investment Management Inc. increased its position in UnitedHealth Group by 2.2% in the 4th quarter. Beese Fulmer Investment Management Inc. now owns 23,271 shares of the healthcare conglomerate’s stock valued at $11,772,000 after buying an additional 511 shares in the last quarter. Finally, Fairvoy Private Wealth LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $420,000. Institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

Shares of UNH opened at $529.71 on Friday. The stock’s fifty day moving average price is $530.85 and its two-hundred day moving average price is $564.52. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a market cap of $487.48 billion, a PE ratio of 34.17, a PEG ratio of 1.48 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 earnings per share. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.63 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms recently issued reports on UNH. Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Wells Fargo & Company lowered their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Finally, Stephens lifted their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.